AC Immune
ACIU
36 hedge funds and large institutions have $93M invested in AC Immune in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 7 closing their positions.
1.07% more ownership
Funds ownership: 26.75% → 27.81% (+1.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less capital invested
Capital invested by funds: $100M → $93M (-$7.29M)
10% less funds holding
Funds holding: 40 → 36 (-4)
15% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 13
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$7.92M |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
+$3.67M |
| 3 |
Renaissance Technologies
New York
|
+$708K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$467K |
| 5 |
PC
PA Capital
Richmond,
Virginia
|
+$409K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.89M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$1.24M |
| 3 |
BFM
Boothbay Fund Management
New York
|
-$620K |
| 4 |
Millennium Management
New York
|
-$553K |
| 5 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
-$294K |
ACIU Hedge Fund Activity: Q3 2019 in Review
36 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q3 2019, worth a combined $93M — down 7.3% from $100M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of ACIU and 3 opened new positions — a net loss of 4 holders — while 13 trimmed existing stakes and 11 added.
The largest buyer was BVF Inc, adding an estimated $7.92M. The largest seller was Fidelity Investments, cutting an estimated $6.89M.
- 36 institutional investors held AC Immune (ACIU) as of Q3 2019, down from 40 in Q2 2019.
- Funds reported $93M of AC Immune stock for Q3 2019, down 7.3% quarter-over-quarter.
- 3 funds opened new AC Immune positions in Q3 2019 and 7 closed out, a net change of -4 holders.
- The largest AC Immune buyer in Q3 2019 was BVF Inc, an estimated $7.92M added.
- The largest AC Immune seller in Q3 2019 was Fidelity Investments, an estimated $6.89M sold.
Based on aggregated 13F filings for Q3 2019.